These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33725338)

  • 21. Novel mutations consolidate KCTD7 as a progressive myoclonus epilepsy gene.
    Kousi M; Anttila V; Schulz A; Calafato S; Jakkula E; Riesch E; Myllykangas L; Kalimo H; Topçu M; Gökben S; Alehan F; Lemke JR; Alber M; Palotie A; Kopra O; Lehesjoki AE
    J Med Genet; 2012 Jun; 49(6):391-9. PubMed ID: 22693283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autosomal recessive progressive myoclonus epilepsy with ataxia and mental retardation.
    Coppola G; Criscuolo C; De Michele G; Striano S; Barbieri F; Striano P; Perretti A; Santoro L; Brescia Morra V; Saccà F; Scarano V; D'Adamo AP; Banfi S; Gasparini P; Santorelli FM; Lehesjoki AE; Filla A
    J Neurol; 2005 Aug; 252(8):897-900. PubMed ID: 15742102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KCTD7-related progressive myoclonic epilepsy: Report of 42 cases and review of literature.
    Yoganathan S; Whitney R; Thomas M; Danda S; Chettali AM; Prasad AN; Farhan SMK; AlSowat D; Abukhaled M; Aldhalaan H; Gowda VK; Kinhal UV; Bylappa AY; Konanki R; Lingappa L; Parchuri BM; Appendino JP; Scantlebury MH; Cunningham J; Hadjinicolaou A; El Achkar CM; Kamate M; Menon RN; Jose M; Riordan G; Kannan L; Jain V; Manokaran RK; Chau V; Donner EJ; Costain G; Minassian BA; Jain P
    Epilepsia; 2024 Mar; 65(3):709-724. PubMed ID: 38231304
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Riboldi GM; Monfrini E; Stahl C; Frucht SJ
    Tremor Other Hyperkinet Mov (N Y); 2022; 12():21. PubMed ID: 35949226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.
    Muona M; Berkovic SF; Dibbens LM; Oliver KL; Maljevic S; Bayly MA; Joensuu T; Canafoglia L; Franceschetti S; Michelucci R; Markkinen S; Heron SE; Hildebrand MS; Andermann E; Andermann F; Gambardella A; Tinuper P; Licchetta L; Scheffer IE; Criscuolo C; Filla A; Ferlazzo E; Ahmad J; Ahmad A; Baykan B; Said E; Topcu M; Riguzzi P; King MD; Ozkara C; Andrade DM; Engelsen BA; Crespel A; Lindenau M; Lohmann E; Saletti V; Massano J; Privitera M; Espay AJ; Kauffmann B; Duchowny M; Møller RS; Straussberg R; Afawi Z; Ben-Zeev B; Samocha KE; Daly MJ; Petrou S; Lerche H; Palotie A; Lehesjoki AE
    Nat Genet; 2015 Jan; 47(1):39-46. PubMed ID: 25401298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of induced pluripotent stem cell GZHMCi001-A and GZHMCi001-B derived from peripheral blood mononuclear cells of epileptic patients with KCNC1 mutation.
    Nengqing L; Dian L; Yingjun X; Yi C; Lina H; Diyu C; Yinghong Y; Bing S; Xiaofang S
    Stem Cell Res; 2020 Jul; 47():101897. PubMed ID: 32712483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A KCNC1-related neurological disorder due to gain of Kv3.1 function.
    Clatot J; Ginn N; Costain G; Goldberg EM
    Ann Clin Transl Neurol; 2023 Jan; 10(1):111-117. PubMed ID: 36419348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation of a potassium channel-related gene in progressive myoclonic epilepsy.
    Van Bogaert P; Azizieh R; Désir J; Aeby A; De Meirleir L; Laes JF; Christiaens F; Abramowicz MJ
    Ann Neurol; 2007 Jun; 61(6):579-86. PubMed ID: 17455289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ILAE Genetics Literacy series: Progressive myoclonus epilepsies.
    Cameron JM; Ellis CA; Berkovic SF; ;
    Epileptic Disord; 2023 Oct; 25(5):670-680. PubMed ID: 37616028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IRF2BPL as a novel causative gene for progressive myoclonus epilepsy.
    Gardella E; Michelucci R; Christensen HM; Fenger CD; Reale C; Riguzzi P; Pasini E; Albini-Riccioli L; Papa V; Foschini MP; Cenacchi G; Furia F; Marjanovic D; Hammer TB; Møller RS; Rubboli G
    Epilepsia; 2023 Aug; 64(8):e170-e176. PubMed ID: 37114479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathogenic gene variants and clinical phenotype features of 26 children with progressive myoclonic epilepsy].
    Zhang J; Zhang YH; Chen JY; Ji TY; Yang ZX; Yang XL; Sun W; Zhang LP; Wu XR
    Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):458-464. PubMed ID: 31216804
    [No Abstract]   [Full Text] [Related]  

  • 32. KCNC1-related disorders: new de novo variants expand the phenotypic spectrum.
    Park J; Koko M; Hedrich UBS; Hermann A; Cremer K; Haberlandt E; Grimmel M; Alhaddad B; Beck-Woedl S; Harrer M; Karall D; Kingelhoefer L; Tzschach A; Matthies LC; Strom TM; Ringelstein EB; Sturm M; Engels H; Wolff M; Lerche H; Haack TB
    Ann Clin Transl Neurol; 2019 Jul; 6(7):1319-1326. PubMed ID: 31353862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new SCARB2 mutation in a patient with progressive myoclonus ataxia without renal failure.
    Perandones C; Pellene LA; Micheli F
    Mov Disord; 2014 Jan; 29(1):158-9. PubMed ID: 24339182
    [No Abstract]   [Full Text] [Related]  

  • 34. Two sisters with myoclonus and ataxia.
    Pereira M; Durães J; Macário MDC
    Pract Neurol; 2020 May; 20(3):249-252. PubMed ID: 32161095
    [No Abstract]   [Full Text] [Related]  

  • 35. A novel SCARB2 mutation in progressive myoclonus epilepsy indicated by reduced β-glucocerebrosidase activity.
    Zeigler M; Meiner V; Newman JP; Steiner-Birmanns B; Bargal R; Sury V; Mengistu G; Kakhlon O; Leykin I; Argov Z; Abramsky O; Lossos A
    J Neurol Sci; 2014 Apr; 339(1-2):210-3. PubMed ID: 24485911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A homozygous mutation in human PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome.
    Bassuk AG; Wallace RH; Buhr A; Buller AR; Afawi Z; Shimojo M; Miyata S; Chen S; Gonzalez-Alegre P; Griesbach HL; Wu S; Nashelsky M; Vladar EK; Antic D; Ferguson PJ; Cirak S; Voit T; Scott MP; Axelrod JD; Gurnett C; Daoud AS; Kivity S; Neufeld MY; Mazarib A; Straussberg R; Walid S; Korczyn AD; Slusarski DC; Berkovic SF; El-Shanti HI
    Am J Hum Genet; 2008 Nov; 83(5):572-81. PubMed ID: 18976727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compound heterozygous
    Burke EA; Sturgeon M; Zastrow DB; Fernandez L; Prybol C; Marwaha S; Frothingham EP; Ward PA; Eng CM; Fresard L; Montgomery SB; Enns GM; Fisher PG; Wolfe LA; Harding B; Carrington B; Bishop K; Sood R; Huang Y; Elkahloun A; Toro C; Bassuk AG; Wheeler MT; Markello TC; Gahl WA; Malicdan MCV
    J Neurogenet; 2021; 35(2):74-83. PubMed ID: 33970744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive myoclonus epilepsy and ceroidolipofuscinosis 14: The multifaceted phenotypic spectrum of KCTD7-related disorders.
    Mastrangelo M; Sartori S; Simonati A; Brinciotti M; Moro F; Nosadini M; Pezzini F; Doccini S; Santorelli FM; Leuzzi V
    Eur J Med Genet; 2019 Dec; 62(12):103591. PubMed ID: 30500434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 'North Sea' progressive myoclonus epilepsy: phenotype of subjects with GOSR2 mutation.
    Boissé Lomax L; Bayly MA; Hjalgrim H; Møller RS; Vlaar AM; Aaberg KM; Marquardt I; Gandolfo LC; Willemsen M; Kamsteeg EJ; O'Sullivan JD; Korenke GC; Bloem BR; de Coo IF; Verhagen JM; Said I; Prescott T; Stray-Pedersen A; Rasmussen M; Vears DF; Lehesjoki AE; Corbett MA; Bahlo M; Gecz J; Dibbens LM; Berkovic SF
    Brain; 2013 Apr; 136(Pt 4):1146-54. PubMed ID: 23449775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel SCARB2 mutation causing late-onset progressive myoclonus epilepsy.
    Higashiyama Y; Doi H; Wakabayashi M; Tsurusaki Y; Miyake N; Saitsu H; Ohba C; Fukai R; Miyatake S; Joki H; Koyano S; Suzuki Y; Tanaka F; Kuroiwa Y; Matsumoto N
    Mov Disord; 2013 Apr; 28(4):552-3. PubMed ID: 23325613
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.